SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-037948
Filing Date
2022-07-07
Accepted
2022-07-07 16:07:43
Documents
14
Period of Report
2022-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea162589-8k_bespoke.htm   iXBRL 8-K 25300
2 AMENDMENT NO. 1 TO BYLAWS ea162589ex3-1_bespoke.htm EX-3.1 4722
3 AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT ea162589ex10-1_bespoke.htm EX-10.1 6629
  Complete submission text file 0001213900-22-037948.txt   210542

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bspk-20220630.xsd EX-101.SCH 2980
5 XBRL LABEL FILE bspk-20220630_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bspk-20220630_pre.xml EX-101.PRE 22373
8 EXTRACTED XBRL INSTANCE DOCUMENT ea162589-8k_bespoke_htm.xml XML 3381
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 221071743
SIC: 2834 Pharmaceutical Preparations